Related references
Note: Only part of the references are listed.Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review
Hamid Aria et al.
ANALYTICAL BIOCHEMISTRY (2022)
Nanobodies as molecular imaging probes
Sarah Barakat et al.
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Nanobody-based CAR-T cells for cancer immunotherapy
Pouya Safarzadeh Kozani et al.
BIOMARKER RESEARCH (2022)
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells
Tijs Merckaert et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Nanobodies: a tool to open new horizons in diagnosis and treatment of prostate cancer
Maryam Hosseindokht et al.
CANCER CELL INTERNATIONAL (2021)
EGFR and anti-EGFR nanobodies: review and update
Jafar Sharifi et al.
JOURNAL OF DRUG TARGETING (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Nanobodies, the potent agents to detect and treat the Coronavirus infections: A systematic review
Hamed Zare et al.
MOLECULAR AND CELLULAR PROBES (2021)
Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers
Yohei Kitamura et al.
SCIENCE ADVANCES (2021)
Nanobody-Based Quantification of GTP-Bound RHO Conformation Reveals RHOA and RHOC Activation Independent from Their Total Expression in Breast Cancer
Laura Keller et al.
ANALYTICAL CHEMISTRY (2021)
Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials
Laura Sanchez-Garcia et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Triple negative breast cancer: A thorough review of biomarkers
Jesse Lopes da Silva et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function
Shima Moradi-Kalbolandi et al.
MOLECULAR IMMUNOLOGY (2020)
Preparation of RGD4C fused anti-TNFα nanobody and inhibitory activity on triple-negative breast cancer in vivo
Xuemei Ji et al.
LIFE SCIENCES (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix
Noor Jailkhani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Targeted Therapies for Triple-Negative Breast Cancer
Tomas G. Lyons
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
A Nanobody Against Cytotoxic T-Lymphocyte Associated Antigen-4 Increases the Anti-Tumor Effects of Specific CD8+ T Cells
Zhuoran Tang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
In vivo tumor-suppressing and anti-angiogenic activities of a recombinant anti-CD3ε nanobody in breast cancer mice model
Azadeh Sharif Khatibi et al.
IMMUNOTHERAPY (2019)
Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3
Sunanda Singh et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2018)
Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival
Danya Liu et al.
JCI INSIGHT (2018)
Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival
Vasilena Gocheva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
Yaozhong Hu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy
Yuyuan Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer
Xuemei Ji et al.
CANCER LETTERS (2017)
Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer
Aram S. A. van Brussel et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
Marina Bacac et al.
CLINICAL CANCER RESEARCH (2016)
Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies
Ema Romao et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Remodelling the extracellular matrix in development and disease
Caroline Bonnans et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells
Hamed Zare et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
In Vivo Neutralization of Botulinum Neurotoxins Serotype E with Heavy-chain Camelid Antibodies (VHH)
Hamid Bakherad et al.
MOLECULAR BIOTECHNOLOGY (2013)
A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis
Katrien Van Impe et al.
BREAST CANCER RESEARCH (2013)
The tumor microenvironment is a dominant force in multidrug resistance
Ana Luisa Correia et al.
DRUG RESISTANCE UPDATES (2012)
Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin
Parag P. Shah et al.
CANCER LETTERS (2011)
Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis
Si-Guang Xu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Proteomic Molecular Portrait of Interface Zone in Breast Cancer
Suki Kang et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Expression of EGFRvIII in Thyroid Carcinoma: Immunohistochemical Study by Camel Antibodies
Kobra Omidfar et al.
IMMUNOLOGICAL INVESTIGATIONS (2009)
A single-step procedure of recombinant library construction for the selection of efficiently produced llama VH binders directed against cancer markers
Damjana Kastelic et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Rob C. Roovers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo
E Dolk et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma
A Horiuchi et al.
LABORATORY INVESTIGATION (2003)
Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters
G Fritz et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
